WORCESTER, Mass., Nov. 5, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, submitted its product dossier to the Ministry of Health in Damascus, Syria on Sunday.
